Robert J. Heine - Concepedia

Author

Robert J. Heine

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

C. D. A. Stehouwer, D. M. Nathan, J M Dekker, J. Wainstein, Marja-RiittaTaskinen, R Heine, R J Heine, R. Heine, R. J Heine, R. J. HEINE

438

Publications

45.6K

Citations

103

H-Index

172

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Maastricht University Medical Centre Amsterdam Public Health Eli Lilly (United States)

About

Robert J. Heine is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	50	92	14.6K
2	Health Sciences	29	43	5.6K
3	Engineering	1	1	63
4	Management	1	1	27
5	Natural Sciences	1	1	55

Robert J. Heine

257

Publications

36.6K

Citations

H-Index

Page 1

	Year	Citations
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial John Dormandy, B Charbonnel, D.J.A. Eckland, The Lancet Diabetes ManagementCardiovascular DiseaseHealth PolicyDiabetesSecondary Prevention	2005	4.1K
Translating the A1C Assay Into Estimated Average Glucose Values David M. Nathan, J.C. Kuenen, Rikke Borg, Diabetes Care	2008	1.8K
Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria K. Borch‐Johnsen, Andrew Neil, Beverley Balkau, The Lancet Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth PolicyGlobal Health	1999	1.3K
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy David M. Nathan, John B. Buse, Mayer B. Davidson, Diabetes Care HypertensionObesityMetabolic SyndromeDiabetes EpidemiologyInsulin Delivery	2006	1.2K
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study Craig J. Currie, John R. Peters, Aodán Tynan, The Lancet Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyDiabetesType 2	2010	875
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes Robert J. Heine, Luc F. Van Gaal, Don Johns, Annals of Internal Medicine	2005	794
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study Cynthia J. Girman, Thomas Rhodes, Giel Nijpels, Circulation	2005	625
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. Femmie de Vegt, Joost Dekker, Agnes Jager, PubMed	2001	594
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Stefano Del Prato, Steven E. Kahn, Imre Pávó, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineInsulin Management	2021	586
Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study Ronald M.A. Henry, Piet J. Kostense, Griët Bos, Kidney International GlomerulonephritisHemodialysisUrologyRenal DiseaseRenal Function	2002	543

Page 1